Your browser doesn't support javascript.
loading
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication.
Hjerpe, A; Ascoli, V; Bedrossian, C W M; Boon, M E; Creaney, J; Davidson, B; Dejmek, A; Dobra, K; Fassina, A; Field, A; Firat, P; Kamei, T; Kobayashi, T; Michael, C W; Önder, S; Segal, A; Vielh, P.
Affiliation
  • Hjerpe A; Division of Clinical Pathology/Cytology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Ascoli V; Department of Radiological, Oncological and Pathological Sciences, Sapienza University, Rome, Italy.
  • Bedrossian CW; Rush University Medical College, Chicago, IL, USA.
  • Boon ME; Leiden Cytology and Pathology Laboratory, Lieveren, The Netherlands.
  • Creaney J; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, QEII Medical Centre, Perth, WA, Australia.
  • Davidson B; Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Dejmek A; Department of Laboratory Medicine in Malmö, Lund University, Malmö University Hospital, Malmö, Sweden.
  • Dobra K; Division of Clinical Pathology/Cytology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.
  • Fassina A; Department of Medicine, University of Padova, Padova, Italy.
  • Field A; Department of Anatomical Pathology, St Vincents Hospital, Sydney, NSW, Australia.
  • Firat P; Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Kamei T; Division of Pathology, Yamaguchi Grand Medical Center, Hofu, Japan.
  • Kobayashi T; Cancer Education and Research Center, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Michael CW; Department of Pathology, Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, OH, USA.
  • Önder S; Department of Pathology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Segal A; Department of Tissue Pathology, PathWest Laboratory Medicine WA, QE2 Medical Centre, Perth, WA, Australia.
  • Vielh P; Department of Biopathology, Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
Cytopathology ; 26(3): 142-56, 2015 Jun.
Article de En | MEDLINE | ID: mdl-26052757
ABSTRACT

OBJECTIVE:

To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma. DATA SOURCES Cytopathologists with an interest in the field involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC) contributed to this update. Reference material includes peer-reviewed publications and textbooks. RATIONALE This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in Cape Town.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mésothéliome Type d'étude: Diagnostic_studies / Guideline / Qualitative_research Limites: Humans Langue: En Journal: Cytopathology Sujet du journal: PATOLOGIA Année: 2015 Type de document: Article Pays d'affiliation: Suède

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mésothéliome Type d'étude: Diagnostic_studies / Guideline / Qualitative_research Limites: Humans Langue: En Journal: Cytopathology Sujet du journal: PATOLOGIA Année: 2015 Type de document: Article Pays d'affiliation: Suède